About BAMS Angel Fund
BAMS Angels Fund is an early-stage investment fund organisation focused on investment rounds between EUR 1 and 4 million. BAMS Angels Fund I (BAF I) was created in 2005 by bringing together 30 individual œangel investors and selected institutional investors under the management of an experienced investment team. It invested in 9 early-stage projects in and around Belgium. In 2009, Michel Helbig de Balzac, Maurice Olivier and Bart Luyten launched BAMS Angels Fund II (BAF II) with the aim of scaling up and leveraging the positive experience of BAF I. The target size of BAMS Angels Fund II is upwards of EUR 20 million. BAMS Angels Fund aims to cover the equity gap faced by most promising start-up companies on their path towards profitable growth. The Fund has the resources, knowledge, experience and agility to respond to the financial and management needs of those companies, and to work side-by-side with them towards the achievement of successful exits.
Want to inform investors similar to BAMS Angel Fund about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
BAMS Angel Fund Investments
BAMS Angel Fund has made 6 investments. Their latest investment was in Bone Therapeutics as part of their Series D on January 1, 2013.
BAMS Angel Fund Investments Activity
Angel - II
BAMS Angel Fund Fund History
2 Fund Histories
BAMS Angel Fund has 2 funds, including BAMS Angels Fund II.
BAMS Angel Fund Team
2 Team Members
BAMS Angel Fund has 2 team members, including current Managing Partner, Michel Helbig de Balzac.